Breastfeeding women with hepatitis B minor triple positive should not breastfeed their children while taking propofol tenofovir. Propofol Tenofovir Fumarate Tablets inhibit the hepatitis B virus and are indicated for the treatment of adult and adolescent patients suffering from chronic hepatitis B, wherein adolescents should be satisfied that they are 12 years of age and older and weigh at least 35 kg and above. The drug should be contraindicated in people who are allergic to the product. The risk of the drug for breastfeeding children cannot be ruled out at this time, so it is recommended that the drug should not be used for treatment during breastfeeding, and similarly, breastfeeding is not recommended for those taking the drug. Common adverse reactions to the current use of the drug are headache, dizziness, vomiting, nausea, bloating, diarrhea, abdominal pain, fatigue, rash, itching, elevated alanine aminotransferase, arthralgia. Specific medication should be administered under the guidance of a specialist.